, Mean tumor volumes and estimated ID8 tumor growth curves in control mice or mice treated with paclitaxel, SU5416 or their combination

<p><b>Copyright information:</b></p><p>Taken from "Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer"</p><p>http://www.translational-medicine.com/content/6/1/2</p><p>Journal of Translational Medicine 2008;6():2-2.</p><p>Published online 8 Jan 2008</p><p>PMCID:PMC2235830.</p><p></p> , Estimated difference between the observed mean tumor volume in animals receiving combined paclitaxel/SU5416 therapy and a predicted tumor volume assuming additive effects for the two individual drugs with 95% confidence intervals